Pharm Neuro: Seizures, Dementia & Parkinson's

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/124

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:54 PM on 1/28/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

125 Terms

1
New cards

pathophysiology of seizure disorder

excess glutamate receptor excitatory activity, excess Ca or Na ion conductance, and inadequate GABA receptor inhibitory activity (balancing issue due to abnormal discharge of cerebral neurons)

other neurons recruited relates to seizure type

2
New cards

therapeutic approach to seizure disorders

decrease glutamate activity and increase GABA inhibitory activity

3
New cards

what is the approach to decrease glutamate activity?

decrease activity of voltage gated channels (Na or Ca)

4
New cards

which drugs decrease activity of Na channels, decreasing glutamate activity?

phenytoin, carbamazepine, lamotrigine

5
New cards

which drugs decrease Ca channel activity, decreasing glutamate activity?

ethosuximide, lamotrigine

6
New cards

what is the approach to increase GABA inhibitory activity? what drugs do this?

increase GABA A (maybe B) receptors activity

benzodiazepines (lorazepam)

7
New cards

tonic-clonic seizure tx

Carbamazepine, lamotrigine, valproate

8
New cards

absence seizure tx

ethosuximide, valproate, lamotrigine

9
New cards

myoclonic and atonic seizure tx

valproate, lamotrigine

10
New cards

what two medications can be used in all seizures?

valproate, lamotrigine

11
New cards

what can carbamazepine be used for?

partial seizures, generalized tonic-clonic seizures

12
New cards

what can ethosuximide be used for?

generalized absence seizures

13
New cards

what seizures can gabapentin and phenytoin be used for?

partial

14
New cards

if there is no underlying seizure cause, what are the RFs for recurrence?

structural CNS lesion

abnormal EEG

partial seizure type

FHx

postictal motor paralysis

15
New cards

what is the recurrence rate for patients with 2+ seizure RFs?

100%

16
New cards

what is the recurrence rate for patients with no seizure RFs?

10-15%

17
New cards

which seizure medication has capacity limited enzyme pathway?

phenytoin

18
New cards

what happens when seizure drugs are protein bound?

inactive - only free drug is active

19
New cards

what % for phenytoin is protein bound?

90%

20
New cards

what % of valproate is protein bound?

about 90%. but metabolism is not capacity limited

21
New cards

autoinduction of seizure drugs causes what to occur? what medication demonstrates this?

increase P450 enzymes concentrations (CYP1A2, 2C9, 2D6, 3A4)

carbamazepine mainly after 2-3mo (some with phenytoin)

22
New cards

what are some drug indication guidelines for seizure medications?

AAN, ILAE, NICE, SIGN

23
New cards

what are some acute SEs of anti-seizure drugs that can occur?

w/ higher concentrations: ataxia, sedation, diplopia

idiosyncratic: rash, liver toxicity, marrow toxicity

24
New cards

chronic SEs of anti-seizure drugs

peripheral neuropathy, cerebellar atrophy, weight gain

osteoporosis

25
New cards

Carbamazepine, phenytoin, and valproate use for 6 months is comparable to chronic corticosteroid use and can lead to what SE?

osteoporosis

26
New cards

how should a patient be switched between seizure medications?

up-titrate new drug to seizure control or minimum effective dose

THEN

down-titrate drug being replaced, continuing to increase new drug as needed

27
New cards

what impacts can anti-seizure drugs have in women of child-bearing age?

teratogenicity

BCP interactions

reduced fertility

28
New cards

valproate impacts in PG

neural tube defects

impaired cognitive development

29
New cards

seizure treatment considerations in children

more rapid seizure control

higher dosing relative to weight

30
New cards

lamotrigine (lamictal) MoA & Indications

blocks sustained repetitive neuron firing and prolongs inactivation of Na channels (maybe Ca channels) used for mono therapy or add-on in generalized or partial seizures

31
New cards

lamotrigine SE/ADRs

dizziness, N/V

ataxia

blurry/double vision

rash

osteoporosis

32
New cards

how does lamotrigine impact other anti-seizure medications?

decreases carbamazepine and phenytoin

increases valproate

33
New cards

what anti-seizure drug should folate be taken with?

lamotrigine

34
New cards

carbamazepine class, indication & moa

tricyclic anti-seizure drug for generalized tonic-clonic and partial seizures that works by decreasing synaptic release glutamate and inhibiting Na channels

35
New cards

carbamazepine SE/ADRs

nausea, HA

ataxia

hyponatremia

arrhythmia

alopecia

bone marrow suppression

osteoporosis

36
New cards

carbamazepine PG

D

lactation: no

37
New cards

phenytoin (dilantin) class, indications & moa

cyclic ureides anti-seizure drug for partial and generalized tonic-clinic seizures that limits repetitive firing of neurons and inhibits Na channels

38
New cards

phenytoin (dilantin) SE/ADRs & PG

gingival hyperplasia

folic acid, Vit D deficiency

peripheral neuropathy

nystagmus, ataxia

hypotension

decreased mentation

osteoporosis

overdose -> death

PG D

39
New cards

which medication needs close dental follow up and good dental hygiene?

phenytoin - gingival hyperplasia

40
New cards

fosphenytoin

prodrug for phenytoin given as IM or IV for status epilepticus

41
New cards

valproic acid (depakote) class, indications & moa

anticonvulsant for seizures (generalized tonic-clonic, absence, myoclonic, tonic), Mania, mood stabilization, migraine px

increases GABA concentration pre- and post- synapse

42
New cards

valproic acid (depakote) SE/ADRs & PG

drowsiness, sedation

nausea

tremor

hepatotoxicity, pancreatitis

osteoporosis

weight gain

PG D

43
New cards

valproic acid (depakote) dosing

divided doses if >250mg/day oral

44
New cards

ethosuximide (zarontin) class, indications & moa

succinimide anti-seizure medication for petit mal or absence seizures in children

reduced low-threshold Ca currents

45
New cards

ethosuximide (zarontin) SE/ADRs

N/V, anorexia, hiccups

drowsiness

blood dyscrasia

SLE

46
New cards

ethosuximide (zarontin) substrate

CYP3A4 (inducers of this with decrease drug effects; inhibitors of this will increase drug effects)

47
New cards

topiramate (topamax) indications & moa

generalized tonic-clonic, partial, absence seizures and migraines

reduced voltage gated Na currents, enhance GABA A receptor currents and inhibits glutamate receptor

48
New cards

topiramate (topamax) SE/ADRs & PG

dizziness, nausea, nystagmus, in-coordination

cognitive dysfunction

metabolic acidosis

nephrolithiasis

PG D

49
New cards

what interferes with BCPs?

topiramate (topamax)

50
New cards

what is a weak carbonic anhydrase inhibitor?

topiramate (topamax)

51
New cards

abrupt discontinuation of what drug can cause seizures?

topiramate (topamax)

52
New cards

levetiracetam (keppra) indications

myoclonic, partial-onset and tonic-clonic seizures

53
New cards

levetiracetam (keppra) SE/ADRs

increase BP

AKI

CNS depression, Behavior problems

muscle weakness

eosinophilia, hematologic changes

SJS-TEN

54
New cards

levetiracetam (keppra) dosing

up-titrate and down-titrate

renal dosing GFR<80

55
New cards

lorazepam (Ativan) class, indications & moa

benzodiazepine for anxiety, operative amnesia, status epilepticus

potentiates GABA A receptor

56
New cards

lorazepam (Ativan) SE/ADR & PG

sedation, dizziness, confusion, coma

hypoactive reflexes

respiratory depression

PG D

57
New cards

what medication is contraindicated in sleep apnea and acute narrow angle glaucoma?

lorazepam

58
New cards

lorazepam dosing may need to be decreased if it is used chronically with what drug?

valproate

59
New cards

categories of dementia medications

acetyl cholinesterase inhibitors

NMDA receptor antagonists

anti-amyloid

60
New cards

pathophys of Alzheimer's

acetylcholine deficit in hippocampus

excess glutamate signaling -> increased NMDA receptor Ca channel activity -> secondary cascades -> neuronal cell death

61
New cards

alzheimer's therapeutic approach

inhibit acetylcholine metabolism (inhibit acetylcholinesterase)

reduce cell death by inhibiting NMDA receptor activity

62
New cards

donepezil (aricept) class, indications & moa

CNS acetylcholinesterase inhibitor that increases acetylcholine concentration in hippocampus for Alzheimer's dementia - slows progression

63
New cards

donepezil (aricept) SE/ADR

insomnia, HA

diarrhea, anorexia

hypotension

cholinergic crisis (N/V, salvation, sweating, bradycardia)

64
New cards

what medication may pose an increased risk for extra-pyramidal reactions with co-administered anti-psychotics?

donepezil (aricept)

65
New cards

memantine (Namenda) class, indications & moa

NMDA receptor antagonist prevents excess Ca ion influx for moderate-severe alzheimers

66
New cards

memantine (Namenda) SE/ADRs

confusion, fatigue, HA, hallucinations, aggression

HTN

67
New cards

what two Alzheimer's medications can be co-administered?

donepezil and memantine

68
New cards

aducanumab-avwa (aduhelm) class, indications & moa

anti-amyloid monoclonal antibody for mild cognitive impairment or Alzheimer's

reduces amyloid beta plaques in cerebral vasculature

69
New cards

aducanumab-avwa (aduhelm) SE/ADRs

ARIA (amlyoid related imaging abnormalities) or ARIA-E (edema) or ARIA-H (hemosiderin)

AMS (confusion, delirium, disorientation, HA, visual disturbances) - often within 8 months

70
New cards

which medication can cause ARIA and AMS?

aducanumab-avwa (aduhelm)

71
New cards

what medications requires a brain MRI before treatment, week 7 and 12?

aducanumab-avwa (aduhelm) - due to ARIA

72
New cards

aducanumab-avwa (aduhelm) administration

IV

73
New cards

dextromethorphane/quinidine (neudexta) class & indications

NMDA receptor antagonist for psuedobulbar affect (PBA) and off-label for agitation and aggression in dementia

74
New cards

dextromethorphane/quinidine (neudexta) moa

may bind to sigma-1 receptors in brain

quinidine is used to delay metabolism

75
New cards

dextromethorphane/quinidine (neudexta) SE/ADRs

D/V

Dizziness, weakness

cough

peripheral edema

serotonin syndrome

76
New cards

dextromethorphane/quinidine (neudexta) contraindications

prolonged QTc, HF, AV block

*get ECG

grapefruit juice

77
New cards

Parkinson's Disease (PD)

loss of dopaminergic cells in substantial nigra - NT imbalance -> prominent motor changes and widespread neurologic symptoms with involvement of vagus N, spinal cord and peripheral autonomic system

78
New cards

PD symptoms

motor: tremor, rigidity, akinesia/bradykinesia, postural instability, gait abnormalities

nonmotor: sleep disturbances, fatigue, speech, pain, dysesthesia, vision, autonomic (drool, dysphagia, ortho hypotension), psych (A&D, dementia, psychosis)

motor fluctuation, akathisia, dyskinesia

79
New cards

PD severity: unified PD rating scale (UPDRS)

1: mention, behavior, mood

2: ADLs

3: motor

4: complications of therpay

5: modified Hoehn & Yahoo stage (symptom severity)

6: Schwab & England ADLs

80
New cards

does dopamine cross BBB?

no

81
New cards

levodopa metabolism

by dopadecarboxylase (DDC) in plasma -> reducing levodopa available to cross BBB into CNS

by COMT in serum and CNS to 3-OMD that crosses BBB but isn't effective -> blocking COMT in CNS leaves more levodopa to be converted to dopamine

carbidopa blocks DDC

82
New cards

classes for PD

anticholinerics

NMDA receptor antagonist

MAO-B inhibitors

dopamine agonists and supplements

COMT inhibitors

83
New cards

how do anticholinergics work in PD?

decrease D and Schedule imbalance -> increase D levels relatively

84
New cards

how do NMDA receptor antagonists work in PD?

modulate levodopa impact on NMDA receptors -> bradykinesia, rigidity, tremor

85
New cards

how do MAO-B inhibitors work in PD?

MAO-A metabolizes NE, serotonin, dopamine

MAO-B selectively metabolizes dopamine

inhibition -> increase CNS dopamine levels

86
New cards

how do dopamine agonist and supplements work in PD?

agonists stimulate dopamine receptors directly

dopamine supplement - replacement therapy

87
New cards

how do COMT inhibitors work in PD?

decrease levodopa metabolism to 3-OMD allowing more to be metabolized to dopamine

88
New cards

benzotropine (cogentin) class, indications & moa

anticholinergic for PD and extrapyramidal symptoms

inhibits ACh receptor

89
New cards

benzotropine (cogentin) SE/ADRs

dry mouth

blurry vision

constipation, urinary retention

sedation, cognitive impairment, hallucinations

orthostatic hypotension

temperature insensitivity

90
New cards

what PD symptoms does benzotropine (cogentin) help?

tremor and drooling but not as effective for bradykinesia, rigidity and gait

91
New cards

what medication should be avoided in patients over 70yo?

benzotropine (cogentin)

and caution in dementia

92
New cards

amantadine (symmetrel) class, indications, moa

NMDA receptor inhibitor for mild PD symptoms that decreases levodopa injury to NMDA receptor

93
New cards

amantadine (symmetrel) SE/ADRs

nausea, dizziness, hallucinations, restlessness, insomnia

livedo reticularis, peripheral edema

orthostatic hypotension

94
New cards

amantadine (symmetrel) dosing

dose by CrCl

avoid in CKD and elderly (anticholinergic)

95
New cards

Osmolex ER

long acting formulation of amantadine (symmetrel) for PD dyskinesia and drug-induced extra-pyramidal symptoms

96
New cards

selegiline (eldepryl) class, indications & moa

MAO-B inhibitor for PD and depression

at therapeutic doses for PD it inhibits MAO-B enzyme -> rise in available dopamine in CNS

97
New cards

selegiline (eldepryl) SE/ADRs

N/D

confusion, HA, hallucinations

dyskinesias, jitteriness

orthostatic hypotension

98
New cards

selegiline (eldepryl) contraindications

bipolar disorder

other drugs, alcohol, tyramine (higher dose -> HTN crisis)

99
New cards

selegiline (eldepryl) formulations & dosing

oral disintegrating tablet or capsule

limit 10mg/day

topical patch (achieves higher doses)

100
New cards

ropinirole (requip) class, indications & moa

non-ergot-derived dopamine (D3) agonist (directly stimulates D3 receptor) for PD and restless leg syndrome

initial therapy alone or add-on to levodopa/carbidopa